desipramine has been researched along with ipodate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Dratman, MB; Gordon, JT; Greenberg, J; Tomlinson, EE | 1 |
2 other study(ies) available for desipramine and ipodate
| Article | Year |
|---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
An acute dose of desmethylimipramine inhibits brain uptake of [125I]3,3',5-triiodothyronine (T3) in thyroxine-induced but not T3-induced hyperthyroid rats: implications for tricyclic antidepressant therapy.
Topics: Analysis of Variance; Animals; Antidepressive Agents, Tricyclic; Brain; Desipramine; Dose-Response Relationship, Drug; Hyperthyroidism; Hypothyroidism; Iodide Peroxidase; Iodine Radioisotopes; Ipodate; Male; Rats; Rats, Sprague-Dawley; Thyroxine; Time Factors; Triiodothyronine | 1994 |